journal article·2023-10Open access

Head-to-head comparison of in vitro and in vivo efficacy of pHLIP-conjugated anti-seed gamma peptide nucleic acids

Karishma Dhuri, Tibo Duran, Bodhisattwa Chaudhuri, Frank J. Slack, Ajit Vikram, Peter M. Glazer, Raman Bahal

Cell Reports Physical Science· Volume 4· Issue 10

Abstract

Gamma peptide nucleic acids (γPNAs) have recently garnered attention in diverse therapeutic and diagnostic applications. Serine and diethylene-glycol-containing γPNAs have been tested for numerous RNA-targeting purposes. Here, we comprehensively evaluated the in vitro and in vivo efficacy of pH-low insertion peptide (pHLIP)-conjugated serine and diethylene-based γPNAs. pHLIP targets only the acidic tumor microenvironment and not the normal cells. We synthesized and parallelly tested pHLIP-serine γPNAs and pHLIP-diethylene glycol γPNAs that target the seed region of microRNA-155, a microRNA that is upregulated in various cancers. We performed an all-atom molecular dynamics simulation-based computational study to elucidate the interaction of pHLIP-γPNA constructs with the lipid bilayer. We also determined the biodistribution and efficacy of the pHLIP constructs in the U2932-derived xenograft model. Overall, we established that the pHLIP-serine γPNAs show superior results in vivo compared with the pHLIP-diethylene glycol-based γPNA.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · DNA and Nucleic Acid Chemistry

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (75)

Show source-provided references
1. MicroRNAs: target recognition and regulatory functions10.1016/j.cell.2009.01.002 ↗
2. The biological functions of miRNAs: lessons from in vivo studies10.1016/j.tcb.2014.11.004 ↗
3. A review of currently identified small molecule modulators of microRNA function10.1016/j.ejmech.2019.112008 ↗
4. MicroRNA sponges: progress and possibilities10.1261/rna.2414110 ↗
5. Anti-miRNA oligonucleotides: A comprehensive guide for design10.1080/15476286.2018.1445959 ↗
6. Inhibition of microRNA function by antimiR oligonucleotides10.1186/1758-907X-3-1 ↗
7. Small-molecule inhibitors of microrna miR-21 function10.1002/anie.200801555 ↗
8. A structure-specific small molecule inhibits a miRNA-200 family member precursor and reverses a type 2 diabetes phenotype10.1016/j.chembiol.2021.07.006 ↗
9. Small Molecule Inhibition of microRNA-210 Reprograms an Oncogenic Hypoxic Circuit10.1021/jacs.6b11273 ↗
10. MicroRNA-133 controls cardiac hypertrophy10.1038/nm1582 ↗
11. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis10.1038/ni.1798 ↗
12. Transgenic microRNA inhibition with spatiotemporal specificity in intact organisms10.1038/nmeth.1402 ↗
13. Characterizing light-regulated retinal microRNAs reveals rapid turnover as a common property of neuronal microRNAs10.1016/j.cell.2010.03.039 ↗
14. Silencing of microRNAs in vivo with 'antagomirs'10.1038/nature04303 ↗
15. Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development10.3390/jcm9062004 ↗
16. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting10.1016/j.cmet.2006.01.005 ↗
17. LNA-mediated microRNA silencing in non-human primates10.1038/nature06783 ↗
18. Improved targeting of miRNA with antisense oligonucleotides10.1093/nar/gkl183 ↗
19. gamma Peptide Nucleic Acid-Based miR-122 Inhibition Rescues Vascular Endothelial Dysfunction in Mice Fed a High-Fat Diet10.1021/acs.jmedchem.1c01831 ↗
20. Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide10.1126/science.1962210 ↗
21. The peptide nucleic acids (PNAs), powerful tools for molecular genetics and cytogenetics10.1038/sj.ejhg.5201226 ↗
22. A simple gamma-backbone modification preorganizes peptide nucleic acid into a helical structure10.1021/ja0625576 ↗
23. Synthesis and characterization of conformationally preorganized, (R)-diethylene glycol-containing gamma-peptide nucleic acids with superior hybridization properties and water solubility10.1021/jo200482d ↗
24. pHLIP ICG for delineation of tumors and blood flow during fluorescence-guided surgery10.1038/s41598-020-75443-5 ↗
25. Targeting diseased tissues by pHLIP insertion at low cell surface pH10.3389/fphys.2014.00097 ↗
26. Targeting Acidic Diseased Tissues by pH-Triggered Membrane-Associated Peptide Folding10.3389/fbioe.2020.00335 ↗
27. Peptides of pHLIP family for targeted intracellular and extracellular delivery of cargo molecules to tumors10.1073/pnas.1715350115 ↗
28. Ku80-Targeted pH-Sensitive Peptide-PNA Conjugates Are Tumor Selective and Sensitize Cancer Cells to Ionizing Radiation10.1158/1541-7786.MCR-19-0661 ↗
29. Translocation of molecules into cells by pH-dependent insertion of a transmembrane helix10.1073/pnas.0601463103 ↗
30. MicroRNA silencing for cancer therapy targeted to the tumour microenvironment10.1038/nature13905 ↗
31. Next generation miRNA inhibition using short anti-seed PNAs encapsulated in PLGA nanoparticles10.1016/j.jconrel.2020.08.026 ↗
32. Enzyme-Triggered Release of the Antisense Octaarginine-PNA Conjugate from Phospholipase A2 Sensitive Liposomes10.1021/acsabm.9b01022 ↗
33. Principles of nanoparticle design for overcoming biological barriers to drug delivery10.1038/nbt.3330 ↗
34. Understanding and overcoming major barriers in cancer nanomedicine10.2217/nnm.10.23 ↗
35. Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?10.1021/acs.bioconjchem.6b00437 ↗
36. Multivalent Lactobionic Acid and N-Acetylgalactosamine-Conjugated Peptide Nucleic Acids for Efficient In Vivo Targeting of Hepatocytes10.1002/adhm.202202859 ↗
37. Complement activation and hemodynamic changes following intravenous administration of phosphorothioate oligonucleotides in the monkey10.1089/ard.1994.4.201 ↗
38. Integrated Safety Assessment of 2'-O-Methoxyethyl Chimeric Antisense Oligonucleotides in NonHuman Primates and Healthy Human Volunteers10.1038/mt.2016.136 ↗
39. Non-CpG-containing antisense 2'-methoxyethyl oligonucleotides activate a proinflammatory response independent of Toll-like receptor 9 or myeloid differentiation factor 8810.1124/jpet.105.084004 ↗
40. Considerations for the Characterization and Interpretation of Results Related to Alternative Complement Activation in Monkeys Associated with Oligonucleotide-Based Therapeutics10.1089/nat.2015.0593 ↗
41. Single-stranded γPNAs for in vivo site-specific genome editing via Watson-Crick recognition10.2174/1566523214666140825154158 ↗
42. Anti-seed PNAs targeting multiple oncomiRs for brain tumor therapy10.1126/sciadv.abq7459 ↗
43. miR-155 as a diagnostic and prognostic marker in hematological and solid malignancies10.4149/neo_2014_032 ↗
44. Proliferation and Apoptosis of B-Cell Lymphoma Cells under Targeted Regulation of FOXO3 by miR-15510.4084/mjhid.2020.073 ↗
45. microRNA-155 silencing inhibits proliferation and migration and induces apoptosis by upregulating BACH1 in renal cancer cells10.3892/mmr.2012.779 ↗
46. Therapeutic Potential of Chemically Modified, Synthetic, Triplex Peptide Nucleic Acid-Based Oncomir Inhibitors for Cancer Therapy10.1158/0008-5472.CAN-21-0736 ↗
47. Epstein-Barr virus latent membrane protein-1 protects B-cell lymphoma from rituximab-induced apoptosis through miR-155-mediated Akt activation and up-regulation of Mcl-110.3109/10428194.2012.659736 ↗
48. Modular self-assembly of gamma-modified peptide nucleic acids in organic solvent mixtures10.1038/s41467-020-16759-8 ↗
49. Unlocking the potential of chemically modified peptide nucleic acids for RNA-based therapeutics10.1261/rna.079498.122 ↗
50. Targeting the Hypoxic and Acidic Tumor Microenvironment with pH-Sensitive Peptides10.3390/cells10030541 ↗
51. Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity10.1093/narcan/zcab021 ↗
52. Nanoparticle for delivery of antisense gammaPNA oligomers targeting CCR510.4161/adna.25628 ↗
53. Dual-Modality Poly-l-histidine Nanoparticles to Deliver Peptide Nucleic Acids and Paclitaxel for In Vivo Cancer Therapy10.1021/acsami.1c11981 ↗
54. Next-generation poly-L-histidine formulations for miRNA mimic delivery10.1016/j.omtm.2023.03.015 ↗
55. Membrane binding and insertion of a pHLIP peptide studied by all-atom molecular dynamics simulations10.3390/ijms140714532 ↗
56. Focus on PNA Flexibility and RNA Binding using Molecular Dynamics and Metadynamics10.1038/srep42799 ↗
57. Secondary structure of cell-penetrating peptides controls membrane interaction and insertion10.1016/j.bbamem.2010.03.005 ↗
58. pH (low) insertion peptide (pHLIP) inserts across a lipid bilayer as a helix and exits by a different path10.1073/pnas.0914330107 ↗
59. A monomeric membrane peptide that lives in three worlds: in solution, attached to, and inserted across lipid bilayers10.1529/biophysj.107.109967 ↗
60. Tumor-Targeted, Cytoplasmic Delivery of Large, Polar Molecules Using a pH-Low Insertion Peptide
61. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform10.1186/1758-2946-4-17 ↗
62. An Automated Force Field Topology Builder (ATB) and Repository: Version 1.010.1021/ct200196m ↗
63. Testing and validation of the Automated Topology Builder (ATB) version 2.0: prediction of hydration free enthalpies10.1007/s10822-014-9713-7 ↗
64. Pharmacokinetic modeling reveals parameters that govern tumor targeting and delivery by a pH-Low Insertion Peptide (pHLIP)10.1073/pnas.2016605118 ↗
65. Molecular Dynamics Modeling Based Investigation of the Effect of Freezing Rate on Lysozyme Stability10.1007/s11095-022-03358-z ↗
66. GROMACS: fast, flexible, and free10.1002/jcc.20291 ↗
67. Interaction of an antimicrobial peptide with a model lipid bilayer using molecular dynamics simulation10.1021/la900365g ↗
68. Molecular dynamics studies of transportan 10 (tp10) interacting with a POPC lipid bilayer10.1021/jp107763b ↗
69. Interactions of Abeta25-35 beta-barrel-like oligomers with anionic lipid bilayer and resulting membrane leakage: an all-atom molecular dynamics study10.1021/jp107558e ↗
70. Effect of lipid composition on buforin II structure and membrane entry10.1002/prot.22074 ↗
71. Insights into buforin II membrane translocation from molecular dynamics simulations10.1016/j.peptides.2012.09.022 ↗
72. Lipid interaction and membrane perturbation of human islet amyloid polypeptide monomer and dimer by molecular dynamics simulations10.1371/journal.pone.0038191 ↗
73. Conformations of islet amyloid polypeptide monomers in a membrane environment: implications for fibril formation10.1371/journal.pone.0047150 ↗
74. Molecular dynamics simulations of a fluid bilayer of dipalmitoylphosphatidylcholine at full hydration, constant pressure, and constant temperature10.1016/S0006-3495(97)78845-3 ↗
75. Canonical dynamics: Equilibrium phase-space distributions10.1103/PhysRevA.31.1695 ↗